Trial Profile
A Phase 2a study of OPK88004
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Oxyntomodulin (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Jul 2017 New trial record